HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Movement Disorders

The NeurologyLive movement disorders clinical focus page is a source for all the latest news regarding the clinical care of patients with Parkinson disease, essential tremor, Huntington disease, dystonia, ataxia, and more. This page features podcasts, videos, and news about FDA actions, study and clinical trial findings, clinical guideline updates, and interviews with experts in the clinical care of movement disorders.

Rituximab as Initial gMG Treatment, WVE-003 Proves Positive in HD, and Incidence of Guillian-Barré After COVID-19 Vaccination

September 24, 2022

Video

Neurology News Network for the week ending September 24, 2022. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — September 23, 2022

September 23, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 23, 2022.

Episode 73: The Role of Palliative Care in Neurology

September 23, 2022

Podcast

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Ambereen Mehta, MD, MPH.

Migraine Linked to Increased Risk of Parkinson Disease in the Middle-aged and Older Population

September 20, 2022

Article

A study presented at the MDS Congress 2022 found an association between migraine and the incidence of Parkinson disease in the middle-aged and older population.

IncobotulinumtoxinA Supported for the Treatment of Neurological Disorders in Adults

September 19, 2022

Article

Results from a pooled analysis extend and support the safety and the tolerability of the use of incobotulinumtoxinA for the treatment of adults with neurological disorders.

Several Genetic Loci Show Increased Risk of Mortality, Cognitive Impairment in Parkinson Disease

September 19, 2022

Article

One of the identified loci related to clinical progression in Parkinson disease expresses ADORA2A in the cerebellum, which encodes the adenosine A2A receptor, a promising target for therapeutics in PD.

This Week on NeurologyLive® — September 19, 2022

September 19, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

WHO’s 6 Action Steps to Address Parkinson Disease Disparities Globally

September 18, 2022

Article

Nicoline Schiess, MD, MPH, and colleagues offer insight into the recent publication of the World Health Organization’s 6 action steps aimed at addressing global disparities in individuals with Parkinson disease.

Selective Adenosine A2A Antagonist KW-6356 Demonstrates Efficacy, Safety as Adjunct to Levodopa in Parkinson Disease

September 18, 2022

Article

The Parkinson disease agent showed a safe and tolerable profile, with significantly greater improvements in MDS-UPDRS-III scores and OFF time per day.

NeurologyLive® Brain Games: September 18, 2022

September 18, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is stroke and cerebrovascular disease.